Cue Biopharma Inc (CUE)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Cue Biopharma Inc-Aktie (CUE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	27.25% 2.149	2.954	0.421	1.576	3.336
Operating Expenses	15.92% 9.744	11.59	12.72	11.21	12.15
Benefits Costs and Expenses	-	-	12.68	11.07	-
Costs And Expenses	15.92% 9.744	11.59	12.68	11.07	12.15
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Depreciation and Amortization	19.19% 0.08	0.099	0.101	0.098	0.101
Operating Income/Loss	12.04% -7.595	-8.635	-12.30	-9.633	-8.815
Net Interest Income/Expense	66.67% -0.075	-0.045	-0.128	-0.153	-0.188
Nonoperating Income/Loss	3.92% 0.147	0.153	0.042	0.137	0.155
Income/Loss From Continuing Operations Before Tax	27.25% 2.149	2.954	-12.26	-9.496	3.336
Income/Loss From Continuing Operations After Tax	12.19% -7.448	-8.482	-12.26	-9.496	-8.66
Net Income/Loss	12.19% -7.448	-8.482	-12.26	-9.496	-8.66
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	5.67% 100.87	95.46	74.25	6.0354	51.23
Diluted Average Shares	5.67% 100.87	95.46	74.25	6.0354	51.23
Basic Earnings Per Share	22.22% -0.07	-0.09	-0.17	-0.10	-0.17
Diluted Earnings Per Share	22.22% -0.07	-0.09	-0.17	-0.10	-0.17
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%